secwatch.observer — SEC 8-K summary
======================================

Issuer:     GE HealthCare Technologies Inc. (GEHC)
CIK:        0001932393
Form:       8-K
Filed at:   2024-04-30T23:59:59+00:00
Accession:  0001932393-24-000033
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GE HealthCare reports Q1 2024 results: revenue flat organically, margins expand, reaffirms guidance
--------------------------------------------------------------------------------

- Revenues declined 1% to $4.6B; organic revenue approximately flat year-over-year.
- Net income margin improved to 8.0% from 7.9%; Adjusted EBIT margin rose to 14.7% from 14.1%.
- Diluted EPS increased to $0.81 from $0.41; Adjusted EPS rose to $0.90 from $0.85.
- Cash from operations $419M vs $468M; free cash flow $274M vs $325M; repaid $150M debt.
- Reaffirmed full-year 2024 guidance: ~4% organic revenue growth, Adjusted EPS $4.20-$4.35.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1932393/000193239324000033/0001932393-24-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1932393/000193239324000033/gehc-20240430.htm
  HTML page:      https://secwatch.observer/filing/0001932393-24-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer